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LH luteinizing hormone 
LHR luteinizing hormone receptor 
MCT2 monocarboxylate transporter 2 
MCT4 monocarboxylate transporter 4 
MDA malondialdehyde 
MHC II major histocompatibility complex class II 
MIF macrophage migration inhibitory factor 
mRNA messenger ribonucleic acid 
Na2HPO4 disodium hydrogen phosphate 
NADP+ nicotinamide adenine dinucleotide  
NADPH nicotinamide adenine dinucleotide phosphate 
NaH2HPO4.2H2O sodium dihydrogen phosphate dihydrate 
NaOH sodium hydroxide  
NC normal control 
NF-kB nuclear factor-kappa b 
nNOS neuronal nitric oxide synthase 
NO nitric oxide 
NQO1 NAD(P)H dehydrogenase [quinone]1 
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Nrf2 nuclear factor erythroid 2-related factor 2 
O2
- superoxide anion 
OECD organization for economic co-operation and 
development   
OGTT oral glucose tolerance test 
OH- hydroxyl 
ONOO- peroxynitrite 
p53 tumor protein 
PCNA proliferating cell nuclear antigen 
QoL quality of life 
ROO- Peroxyl 
ROS reactive oxygen species 
RT-qPCR reverse transcription quantitative polymerase chain 
reaction 
SDS sodium dodecyl sulphate 
SOD superoxide dismutase 
StAR steroidogenic acute regulatory protein 
TAC total antioxidant capacity 
TBA 2-thiobarbituric acid 
TBARS thiobarbituric acid reactive substances 
TC total cholesterol 
TEP 1,1,3,3-tetraethoxypropane 
TPC total phenolic content  
TG Triglyceride 
TNB 5-thio-2-nitobenzoic acid 
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TNF- α tumor necrosis factor-alpha 
TPTZ 2,4,6-tripyridyl-s-triazine 
Tris-HCl tris(hydroxymethyl)aminomethane-HCl 
TSPO translocator protein 
USM Universiti Sains Malaysia 
w/v weight/ volume 
WC waist circumference 
WHO World Health Organisation 




PERANAN ROTI LEBAH Heterotrigona itama KE ATAS SISTEM 




Obesiti dilaporkan telah menyebabkan stres oksidatif testikular, inflamasi dan 
apoptosis di mana ia menyebabkan kegagalan fungsi reproduktif lelaki manakala roti 
lebah menunjukkan kesan antioksidan, antiradang dan antiapoptosis sepertimana 
dilihat dalam tisu-tisu lain. Walau bagaimanapun, sehingga kini, peranan roti lebah 
Heterotrigona itama ke atas sistem reproduktif lelaki obes belum dilaporkan. Oleh 
sebab itu, objektif kajian ini adalah untuk (i) menilai pH, komposisi dan sifat 
antioksidan roti lebah Heterotrigona itama dan (ii) menentukan peranan roti lebah 
Heterotrigona itama ke atas parameter antropometrik, parameter sperma, stres 
oksidatif testis, keradangan, apoptosis, tingkahlaku seksual dan juga prestasi 
reproduktif dalam tikus jantan yang diberi diet tinggi lemak (HFD). Tiga puluh dua 
tikus Sprague Dawley yang beratnya di antara 250-300 g diletakkan secara dirawak 
dalam empat kumpulan (n=8/kumpulan) yang dinamakan kumpulan kawalan (NC), 
HFD, HFD dengan roti lebah (HFD+B) dan kumpulan HFD dengan ubat anti-obesiti 
orlistat (HFD+O). Roti lebah (0.5g/kg/hari) dan orlistat (10 mg/kg/hari) dibancuh 
dalam air suling dan diberi secara paksaan oral selama 12 minggu. Pada minggu ke 
sepuluh, setiap tikus jantan diletakkan dengan tikus betina yang subur untuk menilai 
tingkahlaku seksual dan prestasi reproduktif tikus jantan. Pada akhir minggu ke -12, 
tikus jantan dibius dan darah serta organ reproduktif diambil untuk menentukan fungsi 
reproduktif. Roti lebah adalah berasid, mempunyai sifat antioksidan in vitro dan 
sembilan sebatian fenol. Roti lebah secara signifikan memperbaiki parameter 
antropometri dan profil lipid dalam tikus yang diberi HFD. Begitu juga dengan roti 
lebah di mana ianya secara signifikan memperbaiki stres oksidatif testis, keradangan, 
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apoptosis dan proliferasi sel germa yang diberi HFD. Seterusnya, roti lebah secara 
signifikan membaikpulih bilangan sperma, viabiliti, motiliti dan mengurangkan 
morfologi sperma tidak normal dan juga nDNA yang terpecah. Tambahan lagi, roti 
lebah secara signifikan meningkatkan hormon reproduktif dan kitaran monofosfat 
guanosin zakar, dan menurunkan kadar leptin, oleh itu meningkatkan jumlah tikus 
dengan intromisi dan ejakulasi yang lebih baik. Kesimpulannya, roti lebah secara 
signifikan meningkatkan sistem reproduktif dalam kalangan tikus jantan yang diberi 
HFD dengan mengurangkan stres oksidatif testis, keradangan, apoptosis dan 
meningkatkan proliferasi sel germa testis. Walau bagaimanapun, kajian lebih lanjut 
diperlukan untuk mengkaji tindakan mekanisma molekul roti lebah dan menentukan   
keselamatannya melalui kajian ketoksikan sebelum ianya digunakan sebagai rawatan  
komplementari dalam kalangan pesakit obes.
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ROLE OF Heterotrigona itama BEE BREAD ON REPRODUCTIVE SYSTEM 
IN MALE RATS FED WITH HIGH-FAT DIET 
ABSTRACT 
Obesity has been reported to cause testicular oxidative stress, inflammation and 
apoptosis thereby resulting in impaired male reproductive function while bee bread, 
on the other hand, exhibits antioxidant, anti-inflammatory and anti-apoptotic 
properties as seen in other tissues. However, to date, the role of Heterotrigona itama 
bee bread on male reproductive system in obesity has not been reported. Therefore, 
the objectives of this study were (i) to assess pH, composition and antioxidant 
properties of Heterotrigona itama bee bread and (ii) to determine the role of 
Heterotrigona itama bee bread on anthropometric parameters, sperm parameters, 
testicular oxidative stress, inflammation, apoptosis, sexual behaviour as well as 
reproductive performance in male rats fed with high-fat diet (HFD). Thirty-two adult 
male Sprague Dawley rats weighing between 250-300 g were randomised into four 
groups (n=8/group), namely normal control (NC), HFD, HFD plus bee bread (HFD+B) 
and HFD plus an anti-obesity drug orlistat (HFD+O) groups. Bee bread (0.5g/kg/day) 
and orlistat (10 mg/kg/day) were suspended in distilled water and given by oral gavage 
for 12 weeks. During the tenth week, each male rat was cohabited with a fertile female 
rat to assess male sexual behaviour and reproductive performance. At the end of 12 
weeks, male rats were anaesthetized and blood, as well as the reproductive organs, 
were removed for the determination of reproductive functions. Bee bread was acidic, 
had in vitro antioxidant properties and nine phenolic compounds. Bee bread 
significantly improved the anthropometric parameters and lipid profile in rats fed with 
HFD. Similarly, bee bread also significantly ameliorated testicular oxidative stress, 
inflammation, apoptosis and germ cell proliferation in rats fed with HFD. Furthermore, 
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bee bread significantly enhanced sperm count, viability, motility, and reduced 
abnormal sperm morphology as well as fragmented nDNA. In addition, bee bread 
significantly increased the levels of reproductive hormones and penile cyclic 
guanosine monophosphate, and decreased leptin level, thereby increasing the number 
of rats with improved intromission and ejaculation as well as mating and fertility 
indices.  In conclusion, bee bread significantly improved the reproductive system in 
male rats fed with HFD by attenuating testicular oxidative stress, inflammation, 
apoptosis and improving testicular germ cell proliferation. However, further studies 
are needed to further investigate the molecular mechanism of action of bee bread and 
to determine its safety via toxicity study before it is used as a complementary treatment 






1.1 Background of study 
Obesity is a multiplex disease comprising of several factors leading to the 
progression of metabolic syndrome (Furukawa et al., 2017). It has recently been 
regarded as an overwhelming worldwide concern which is usually defined as excess 
body weight for a given height, with its accompanying severe health problems and 
having detrimental effects on the various systems in the body (Jayagopal et al. 2005; 
Eleazu et al., 2020; Suleiman et al. 2020a). The risk factors include; abdominal 
adiposity, hypertension, hypercholesteremia, sleep apnea, pulmonary hypertension, 
cardiovascular disease and type 2 diabetes (Gadde et al., 2018), reduction in high‐
density lipoprotein (HDL), increased triglycerides and glucose intolerance (Leisegang 
et al., 2019). Although the physiology and pathophysiology of obesity seem complex, 
it is caused by increased intake of calories combined with a concomitant reduction in 
energy expenditures (Levine et al., 2018). 
Obesity results from the accumulation of fats in the body with the individuals 
being excessively overweight (Zapata et al. 2020). One of the major contributory 
factors to obesity is the intake of excessive dietary fat, encouraged by its deliciousness 
and low satiety effect. Several diets including high-fat diet (HFD) amongst others have 
been implicated in the etiology of obesity (Kang et al. 2017).  
Obesity has since been linked to infertility in couples globally; male obesity 
accounts for 20-70% of the problems and is associated with several adverse 
reproductive outcomes (Amjad et al., 2019).  Ramaraju et al. (2018) report that there 
is evidence of disturbances in the hypothalamic-pituitary-gonadal (HPG) axis that 
eventually affect testosterone and oestrogen levels. These decreased levels of 
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testosterone and oestrogen have a detrimental effect on spermatogenesis. The FSH and 
LH secretions are suppressed as a result of the negative effects of estrogen on the 
hypothalamus by altering the gonadotropin-releasing hormone (GnRH) level (Katib, 
2015).  
Numerous pathological conditions have been attributed to obesity, but the 
corroboration relating to impaired fertility in males with obesity are vague (Bellastella 
et al., 2019). Epidemiological and experimental studies have suggested the implication 
of oxidative stress in the mechanism of abnormal spermatogenesis and impaired 
fertilizing potential in obesity (Sallmén et al., 2006; Nguyen et al., 2007; Ramlau-
Hansen et al., 2007). Oxidative stress is also reported as the major causative factor for 
reproductive abnormalities in obese men, the occurrence of which is demonstrated to 
activate pro-cytotoxic pathways like inflammation and apoptosis (Agarwal et al., 
2012). Oxidative stress is the condition related to harmful cellular damage caused by 
oxygen and oxygen-derived oxidants generally known as reactive oxygen species 
(ROS). The testicular tissues and spermatozoa are very delicate to ROS assault and 
lipid peroxidation which are attributed to the highly rich polyunsaturated fatty acid 
content of sperm membranes. Various studies have reported a negative relationship 
between sperm concentration, motility and sperm-oocyte interaction, and male obesity 
(Codoñer-Franch et al., 2011; Mortazavi et al., 2014), while others reported otherwise 
(Erdemir et al., 2012; Galaly et al., 2014).  
In obese men, reduced sperm concentrations, sperm count and sperm motility 
were compared to lean men (Jensen et al., 2004; Kort et al., 2006; Hammoud et al., 
2008; Paasch et al., 2010), sperm chromatin integrity was also compared in obese and 
lean men subjected to semen analysis at fertility clinics (Kort et al., 2006; Chavarro et 
al., 2010; Rybar et al., 2011; Tunc et al., 2011; Dupont et al., 2013). Increased 
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apoptosis has been reported in spermatozoa of male patients with infertility, infertile 
mice and other rodents, although apoptosis is necessary for cellular homeostasis and 
male germ cell development (Miao et al., 2018). 
Obesity was reported as the leading cause of male (Katib 2015) and female 
(Talmor & Dunphy 2015) subfertility in the last three decades. The relationship 
between HFD and spermatozoa fertilizing capacity was accentuated in a previous 
study which reported decreases in sperm motility and quality, increased sperm DNA 
fragmentation and decreased lactate availability (Ferramosca et al. 2016, Suleiman et 
al. 2020a), which may ultimately result in decreased fertility potential. Sertoli cells 
provide enabling environment for the developing germ cells in the seminiferous 
tubules by ensuring a steady supply of lactate to the germ cells (Heinrich et al. 2020). 
Studies have revealed that metabolized glucose within the Sertoli cells is converted 
into lactate which serves as the substrate for adenosine triphosphate (ATP) production 
in the germ cells, to support spermatogenesis (Sengupta et al. 2020). Therefore, 
decreased germ cell ATP production may negatively affect fertility rates.  
The integrity of sperm chromatin is a possible marker of the quality of sperm, 
decreased fertility and defective embryo development (Oleszczuk et al., 2013). In 
several studies carried out on sperm chromatin integrity showed a positive association 
between sperm nuclear DNA fragmentation and body mass index. Furthermore, 
intracytoplasmic sperm injection success, pregnancy rate and live birth rate are 
negatively influenced by increased paternal body mass index (Umul et al., 2015). 
However, other studies revealed a weak or no association between obesity in males 
and semen parameters (MacDonald et al., 2009; Duits et al., 2010; M Al‐Ali et al., 
2014). Sermondade et al., (2012) found that paternal overweight and obesity are linked 
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to a higher incidence of abnormal sperm parameters such as azoospermia or 
oligozoospermia. 
Some possible mechanisms have been suggested to explain the impact of 
obesity on sperm parameters and male fertility. These include alteration in the 
hypothalamic-pituitary-testis axis, higher levels of leptin (Du Plessis et al., 2010), 
hyperinsulinaemia and increased oxidative stress in the testicular microenvironment 
(Michalakis et al., 2013). A negative association exists between the accumulation of 
fat, concentrations of sex hormone-binding globulin and total testosterone (Mah and 
Wittert, 2010). Consequently, increased inflammation, oxidative stress and lipid 
peroxidation are associated with obesity (Ozata et al., 2002; Vincent et al., 2007; 
Johnson et al., 2012; Furukawa et al., 2017). Increased apoptosis and oxidative stress 
in the sperm of obese male mice have shown the relevance of oxidative stress to sperm 
quality (Palmer et al., 2012). 
The relaxation of the penile vascular smooth muscles and retention of blood in 
the penile spongy tissues orchestrated by nitric oxide (NO) – cyclic guanosine 
monophosphate (cGMP) pathway, is required for the initiation and sustenance of 
penile erection. In erectile dysfunction, besides testosterone decline, penile oxidative 
stress also occurs in obesity through superoxide and reactive oxygen species 
generation (Minhas et al. 2002; Suleiman et al., 2019a). This is supported by reports 
which showed that obese men were 2.5 times likely to have erectile dysfunction (BMJ 
2010), and overweight male juvenile rats fed with hypercaloric diet had impaired 
sexual behaviour (Macrini et al. 2016). 
Bee bread is different from bee pollen. Bee pollen is gathered by scavenging 
bees and conveyed on their hind legs in a pollen bin back to the hive (Disayathanoowat 
et al., 2020).   Bee bread is made from pollen which is gathered by bees, but it is further 
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mixed, preserved and fermented with honey and bee digestive enzymes. Bee bread or 
fermented bee pollen has a higher content of lactic acid when compared with bee 
pollen. It has a high protein and phenolic contents as well as antioxidant activity (Nagai 
et al., 2004). Previous reports have shown that bee bread possesses antioxidant 
(Bakour et al., 2017), antitumor (Sobral et al., 2017), antihypertensive (Khalifa et al., 
2020), antimicrobial (Kowalski and Makarewicz, 2017), neuroprotective (Khalifa et 
al., 2020), anti-inflammatory (Bakour et al., 2017) and anticancer (Zakaria and Haron, 
2018) activities in most organs of the human body. 
1.2 Research problem statement 
Excessive food intake by men has resulted in being overweight and obese 
which could affect various organs including the male reproductive system leading to 
increased subfertility/ infertility. Traditionally, obesity is managed by adjusting one’s 
lifestyle, administration of medications such as orlistat and metformin as well as by 
surgical methods. For decades now, these medications have been known to cause some 
detrimental side effects such as diarrhea, stomach cramp, vomiting and muscle wasting 
thereby necessitating the use of alternative medicine.  
1.3 Justification of the study 
Bee bread has been traditionally consumed for enhancement of male fertility. 
The previous study has reported that date palm pollen (bee pollen) at 120 and 240 
mg/kg/day for 35 days significantly improves sperm parameters (counting, motility, 
morphology and DNA quality) with a concurrent gain in the weights of testis and 
epididymis in normal male rats (Bahmanpour et al., 2015). Furthermore, bee pollen at 
5 to 10 g/kg for 28 days significantly reduces body weight, Lee obesity index, the 
weight of fat in the groin, liver, abdominal cavity, total cholesterol and triglyceride 
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levels in obese mice induced by high cholesterol diet and subcutaneous L-monosodium 
glutamate (Komosinska-Vassev et al., 2015). 
However, it has not been established to date whether bee bread can improve 
male reproductive function in obesity or hyperlipidaemic condition. Therefore, this 
study aimed to determine the role of Malaysian bee bread on the reproductive system 
in male rats fed with a high-fat diet (HFD). 
1.4 General objective 
To determine the role of Heterotrigona itama bee bread on the reproductive 
system in male rats fed with HFD. 
1.5 Specific objectives 
1. To investigate pH, composition and in vitro antioxidant properties of 
Heterotrigona itama bee bread (phase 1 study) 
2. To determine the effects of Heterotrigona itama bee bread on food 
consumption, body weight gain, and body mass index (BMI) and Lee obesity 
index in male rats fed with HFD (phase 2 study). 
3. To investigate the effects of Heterotrigona itama bee bread on biochemical 
parameters (blood glucose, lipid profile, leptin and adiponectin) in male rats 
fed with HFD (phase 2 study). 
4. To determine the effects of Heterotrigona itama bee bread on sperm 
parameters and reproductive hormones (phase 2 study). 
5. To determine the effects of Heterotrigona itama bee bread on sexual behaviour 
and reproductive performance in male rats fed with HFD (phase 2 study). 
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6. To investigate the effects of Heterotrigona itama bee bread on histology of 
epididymal fat and reproductive organs (testis and epididymis) in male rats fed 
with HFD (phase 2 study). 
7. To determine the effects of Heterotrigona itama bee bread on testicular mRNA 
and protein levels of parameters of steroidogenesis, energy metabolism in male 
rats fed with HFD (phase 2 study). 
8. To determine the effects of Heterotrigona itama bee bread on testicular mRNA 
and protein levels of parameters of oxidant-antioxidant status, inflammation, 
apoptosis and germ cell proliferation in male rats fed with HFD (phase 2 study). 
9. To determine the effects of Heterotrigona itama bee bread on sperm 
proteomics in male rats fed with HFD (phase 2 study). 
10. To determine the effects of Heterotrigona itama bee bread on epididymal 
oxidant-antioxidant status in male rats fed with HFD (phase 2 study). 
1.6 Hypothesis  
Heterotrigona itama bee bread significantly improves testicular functions and 
fertility in rats fed with HFD by reducing oxidative stress, inflammation and apoptosis, 






2.1 Obesity  
Obesity is a disease condition associated with significant disturbance in 
biochemical and hormonal levels that can affect various systems leading to several 
diseases such as diabetes mellitus, hypertension, dyslipidemia, cardiovascular disease, 
lung diseases, osteoarthritis, some types of cancer, and certain reproductive and 
metabolic disorders (Hammoud et al., 2008). It can be caused by a combination of 
factors such as excessive food intake, lack of physical activity, medications, endocrine 
disorders, mental disorders, genes and genetic susceptibility (Guyenet and Schwartz, 
2012). 
WHO has reported that more than 1.9 billion adults aged 18 years and above 
were overweight, with over 650 million adults obese in 2016. Similarly, an estimated 
38.2 million children under the age of 5 years were overweight or obese (WHO, 2019). 
The prevalence of obesity has also reached an alarming rate in many developing 
countries including Malaysia in which 29.1% were overweight while 14% were obese 
based on previous National Health and Morbidity Surveys (NHMSs) carried out in 
Malaysia (Nor et al., 2008; Mohamed, 2012; Chan et al., 2017), in comparison with 
some South-East Asian countries such as Vietnam (2.1%), Cambodia (3.9%), Lao 
(5.3%), Myanmar (5.8%), Singapore (6.1%), Philipines (6.4%), Indonesia (6.9%), 
Thailand (10%), and Brunei (14%) (Nor et al., 2008; Mohamed, 2012; Chan et al., 
2017).  
In men, the relationship between the male reproductive system and obesity is 
poorly understood (Fernandez et al., 2011; Fernández et al., 2015).  Some reports have 
shown that obesity in men is associated with a decrease in serum levels of total and 
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free testosterone leading to low sperm count (Du Plessis et al., 2010; Fernandez et al., 
2011). On the other hand, there is a negative correlation between obesity and various 
semen parameters (Oliveira et al., 2017), while a recent study has suggested that there 
is no relationship between increased body mass index (BMI) and sperm DNA (Bandel 
et al., 2015).  
Natural products are chemical compounds or substances produced by living 
organisms which could be derived from plants, animal, microorganisms and marine 
sources. For many years, natural products have been used in the prevention of diseases 
and have also played a very important role in health. The ancient civilizations of the 
North Africans, Indians and Chinese provide written evidence for the use of natural 
sources for treating various diseases (Moudgil and Khalil, 2016). In those early times, 
mandrake was prescribed for pain relief, turmeric possessed blood clotting properties, 
roots of the endive plant were used for the treatment of gall bladder disorders, and raw 
garlic was prescribed for circulatory disorders (Moudgil and Khalil, 2016). These 
natural products are still being used in several countries as alternative medicines 
(Arafat and Rahman, 2017). The role of these products in the treatment of obesity and 
fertility has received increased attention owing to the recent and rapid increase in the 
prevalence of obesity in the developed world (Hruby and Hu, 2015).  
2.2 Definition and classification of obesity 
Obesity is usually caused by an immoderate build-up of fat deposits in the body 
culminating in detrimental consequences on the total wellbeing of an individual (Russo 
et al., 2016). The main factors required for the diagnosis of obesity include a waist-to-
hip ratio (WHR), waist circumference (WC) and BMI. WHR is also a measure for 
some other serious health conditions, however, World Health Organisation (WHO) 
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defined obesity as WHR that is more than 0.90 for males and 0.85 for females 
(Mohamed et al., 2014). Both men and women with WHR greater than 0.8 and 1.0, 
respectively, are prone to health risk due to increased fat distribution and have proven 
to be a more reliable predictor of cardiovascular disease than BMI and WC. Recently, 
there is evidence of WHR as an indicator of health risks (Anusruti et al., 2020). The 
fat distribution around the waist can be calculated as follows: 
WHR = Waist Circumference x Hip circumference (Anusruti et al., 2020) 
2.2.1 Diagnosis of obesity 
In obesity clinics, patients are grouped into co-morbidity risk status based on 
the guidelines provided by clinicians for the recognition, evaluation, and medical care 
of obesity. The International Classification of Diseases Ninth Revision (ICD-9) 
diagnostic code is used to identify patient co-morbidities (Wagner et al., 2016a). Up 
to 50% of the adult population in Organisation for Economic Co-operation and 
Development (OECD) countries have a BMI ≥ 25 Kg/m2) (Pierre, 2016; Booth et al., 
2017).  Table 2.1 outlines the classification of overweight, obesity and waist 
circumference. The various types of obesity are categorized based on their origin 
which is stated in Table 2.2. Overweight results when an individual consumes food 
above his level of activity, leading to a rise in the level of fat storage which is 
precipitated by impairment of the hormonal or metabolic system. 
BMI levels are categorised as follows: Underweight (< 18.5 kg/m2), Normal 
(18.5 – 24.9 kg/m2), and Overweight. Obesity is further divided into Class I Obesity 
(25.0 – 29.9 kg/m2), Class II Obesity (30.0 – 34.9 kg/m2), Class III obesity (35.0 – 
39.9 kg/m2), and Extreme obesity (40 kg/m2) (De Lorenzo et al., 2016). Different 
obesity types have been identified which include central/ abdominal, android or apple 
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peripheral/ visceral, gynaecoid or pear, diffuse, localised, formerly obese, childhood, 
















































Table 2.1: Classification of overweight and obesity by BMI, waist circumference and 
associated disease risk 
 
   Disease risk* (relative to normal 













Underweight <18.5     
Normal 18.5 - 24.9    
Overweight 25.0 - 29.9   Increased  High 
Obesity  30.0 – 34.9 I High  Very high 
 35.0 – 39.9  II Very high Very high 





Adapted from World Health Organization (Suleiman et al., 2019). BMI, Body Mass 
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2.2.2 Management of obesity 
Obesity can be managed by a modification of lifestyle, medications, or bariatric 
surgery (Misra et al., 2009). The modification of life’s style consists of healthy dieting, 
indulging in physical activities and avoidance of high intake of alcohol. On the other 
hand, anti-obesity drugs like orlistat (Suleiman et al., 2020b) and metformin (Nna et 
al., 2019) are universally available and endorsed for long term use, in any case, these 
medications may have longer-term complexities of obesity. Their utilization is related 
to high rates of side effects such as vomiting and abdominal cramping (Waring et al., 
2009). Over the past 50 years, patients with morbid obesity have received bariatric 
surgery as a treatment option (Bardia et al., 2007). It comprises the adjustment of the 
digestive tract by either restricting the gastric volume or changing the route of the food 
bolus creating an element of malabsorption. Bardia et al. (2007) reported that several 
barriers militate against the management of obesity which includes, patient, physician, 
allied health care, health system and socio-economic factors. 
2.3 Male reproductive system 
2.3.1 Structures and functions of male reproductive system 
The main sex organ in males is the testes which are located in the scrotum 
hanging between the upper thighs (Peate, 2016). During the intrauterine life, they grow 
around the adjoining kidneys but, just before birth, they descend into the scrotum. Each 
testis is oval and about ½ inches long by 1 inch wide (Darda, 2017). The Leydig cells 
are responsible for the production of testosterone which in turn stimulates the 
production of sperm and initiates secondary sex characteristics beginning at puberty 
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(Martin, 2016). Spermatogenesis occurs in the seminiferous tubules which are usually 
referred to as the functional units of the testis. Once the sperm cells are produced, they 
move from the seminiferous tubules into the rete testis for further maturation (Sharma 
et al., 2019). 
Sertoli cells present in the seminiferous tubule are known as “mother cells” 
because they nurture sperm cells and provide secretory and structural support during 
the process of spermatogenesis. They also possess follicle stimulating hormone (FSH) 
receptors and are usually stimulated by FSH (Chojnacka et al., 2016). 
The sperm complete their maturation with their flagella becoming motile in the 
epididymis. Furthermore, they are also stored there until the ejaculation. The 
epididymis comprises of three parts: the proximal part known as head or caput 
epididymis which conveys the sperms from the testis, the middle part called the body 
or corpus epididymis and the tail or cauda epididymis which partakes in conveying the 
sperms to the vas deferens (Neto et al., 2016).  
Vas deferens is otherwise called the sperm duct, it moves on its side into the 
abdominal cavity through the inguinal canal and then emerges from the epididymis in 
the scrotum (Jiménez-Reina et al., 2016).  
Consequently, the seminal vesicles are found posterior to the urinary bladder. 
Their main function is to secrete fructose which provides energy for sperm and 
alkalinity to enhance sperm motility (Kalthur and Kalthur, 2017). On the other hand, 
ejaculatory ducts are responsible for receiving sperm from the vas deferens and the 
secretions from the seminal vesicle. The two ejaculatory ducts, therefore, open into the 
urethra (Kalthur and Kalthur, 2017). During ejaculation, the contraction of the smooth 
muscle of the prostate gland helps in the expulsion of semen from the urethra (Jiménez-
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Reina et al., 2016). Urethra then opens into the glans penis and allows for the 
movement of urine and ejaculation of semen (Neto et al., 2016). 
2.3.2 Steroidogenesis in male reproductive system 
Steroidogenesis is responsible for the production of steroid hormones in 
various tissues such as the testis, ovaries and adrenal gland. However, of these 
hormones secreted, testosterone and FSH are the main regulators of spermatogenesis 
(Sanderson, 2006). The Leydig cells under the influence of luteinizing hormone (LH) 
are responsible for the synthesis of androgens referred to as testosterone. Similarly, 
LH is essential for the induction and advancement of spermatogenesis. (Pasquali, 
2006) reported that obese men are usually characterized by decreased levels of 
testosterone due to increasing body weight. On the other hand, the gonadotrophs 
situated in the anterior pituitary synthesize glycoproteins known as FSH which are 
usually controlled by pulses of gonadotropin-releasing hormone (GnRH) (Ilacqua et 
al., 2018).  
FSH acts in conjunction with LH in stimulating the maturation of germ cells 
and induces the formation of Sertoli-Sertoli intracellular tight junctions (Edelsztein 
and Rey, 2019). The combination of FSH and testosterone binds to receptors on the 
Sertoli cells which stimulate the production of cAMP thereby mobilizing and 
transporting cholesterol into the steroidogenic pathway, the cAMP-dependent protein 
kinase (PKA) activates cholesterol from intracellular cholesterol pools. It is then 
transferred into the inner-mitochondria membrane by the action of the steroidogenic 
acute regulatory protein (StAR) and converted to pregnenolone by P450 side chain 
cleave (Bhadula, 2019).  
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Pregnenolone circulates into the smooth endoplasmic reticulum where it is 
converted to progesterone via the action of 3-hydroxysteroid dehydrogenase-4-5 
isomerase (3-HSD) (Wang et al., 2019). Meanwhile, the progesterone is converted to 
17-hydroxy progesterone, then into androstenedione with the aid of 17-hydroxylase 
lyase (P450c17). Following this, the androstenedione is then converted to testosterone 
via the aid of 17-hydroxysteroid dehydrogenase (17-HSD) found on the inner-face of 
mitochondrial inner matrix membrane (O'Donnell et al., 2017). 
2.3.3 Spermatogenesis in male reproductive system 
Spermatogenesis is referred to as an aggregate of processes that take place 
within the seminiferous tubules and comes to a climax in the production of male 
gamete (Griswold, 2015). Spermatogenesis comprises a pool of stem cell, duration of 
the proliferation of spermatogonia, meiosis, spermiogenesis and the release of 
spermatozoa into the testicular tubule lumen (Desai et al., 2017). The process of 
spermatogenesis takes approximately 74 days in humans but more recent studies have 
revealed that it may vary between 42 to 76 days. The daily range of sperm production 
in humans is between 150 and 275 million spermatozoa (Neto et al., 2016) 
2.3.4 Testicular energy metabolism in male reproductive system 
Sertoli cells are the largest reservoirs of lactate in the testis which they prefer 
as the most preferred energy metabolites. These metabolites are produced principally 
from glucose. The glucose transporters (GLUTs) serve as the rate-limiting step for the 
movement of glucose from the extracellular space into germ cells (Oonk et al., 1989). 
The Sertoli cells have at least four GLUTs (GLUT1, 2, 3 and 8) identified till date.  
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However, GLUT8 is not used for the transportation of glucose from the 
extracellular space because it is not present in the plasma layer of Sertoli cells but 
instead, the endoplasmic reticulum layer takes up glucose from the extracellular space 
into the germ cells (Beattie et al., 1984; Yu et al., 2019). Additionally, the germ cells 
are constantly nourished by lactate dehydrogenase (LDH) (Fan et al., 2018). On the 
other hand, the monocarboxylate transporters (MCTs) help in the transportation of 
lactate from Sertoli cells to the germ cells (Figure 2.1). 
Regardless of being a vitality substrate, glucose is not the fundamental 
metabolite utilized for the production of ATP in the Sertoli cells (Bernardino et al., 
2019). Therefore, Sertoli cells can still proceed with their functions irrespective of 
inadequate glucose, as ATP and lactate are produced from the digestion of amino 
acids, glycogen and lipids.  Accordingly, lipid β oxidation is by all accounts the 
fundamental metabolic pathway utilized by Sertoli cells to create vitality (Antognelli 





Figure 2.1: Diagram of Sertoli cell energy metabolism 
   
Acetyl CoA: acetyl coenzyme A, ATP: adenine triphosphate, GLUT: glucose transporter, LDH: lactate dehydrogenase, MCT: monocarboxylic 
transporter, TCA: tricarboxylic acid cycle 
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2.3.5 Male reproductive hormones 
Leydig cells are major sites for the production of circulating androgens known 
as testosterone. In males, for instance, it is vital for the development and maintenance 
of reproductive tissues such as seminal vesicles, epididymis, penis, testis, prostate, 
increase in muscle mass and hair growth in the axilla and pubic region (Cunningham 
et al., 2016). About 95 % of circulating androgenic hormones are produced and 
secreted from the Leydig cells, which is about 6-7 mg per day, and also adrenal cortex.  
Testosterone is synthesized from cholesterol which is often transported via 
translocator protein (TSPO) from the outer mitochondrial membrane to the inner 
mitochondrial membrane and the StAR. Saad et al. (2017) reported that testosterone 
deficiency is usually identified with increased sarcopenia and obesity but treatment 
with testosterone in advanced aged men with testosterone deficiency increases insulin 
resistance, glucose metabolism, and body composition. Similarly, in a study carried 
out on 470 men aged 65 years with low libido to assess the responses to specific sexual 
activities, treatment with testosterone showed increases in testosterone and estradiol 
levels associated with significant changes in sexual activity and desire (Cunningham 
et al., 2016). 
Estradiol is a type of estrogen which plays a basic role in male sexual behaviour 
and function. Microsomal P450 aromatase enzyme is responsible for the metabolism 
of testicular estrogen from testosterone, which converts testosterone to estrogen and 
testosterone/estradiol ratio. In men, it is very vital for modulating libido, erectile 
function, and spermatogenesis. There is an abundance of estrogen receptors and 
aromatase in testis, brain and penis, which are very important for sexual function (Jardí 
et al., 2017). Previous researches have shown that estradiol is present not only in the 
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reproductive tract of the adult male but also in the brain. In animals and humans, there 
are higher concentrations of estradiol in the male reproductive tract and semen than in 
the serum, especially in Leydig and Sertoli cells. Recent research has shown that 
estradiol synthesized by germ cells within the seminiferous tubules contributes 
significantly to the hormonal milieu within the tubules (Schulster et al., 2016). 
Follicle stimulating hormone (FSH) also known as gonadotropins is an 
important manager of gonadal and fertility functions. It is produced by gonadotrophs 
situated in the anterior pituitary (Grinspon et al., 2018). In men, spermatogenesis is 
initiated when FSH binds to the Sertoli cells inside the seminiferous tubules (Zhang et 
al., 2017). Another important function of FSH is the stimulation of the Sertoli cells to 
produce inhibin, whose functions is to suppress the release of FSH from the pituitary, 
thereby decreasing testosterone secretion. This hormone shows a direct correlation 
with Sertoli cell function and sperm number, similarly, inhibin B may be used as a 
marker of spermatogenic activity (Campo et al., 2019).  
Luteinizing hormone (LH) or interstitial cell stimulating hormone secreted by 
gonadotrophs situated in the anterior pituitary (Uemura et al., 2018). It acts in 
conjunction with FSH. Low blood testosterone levels cause the release of the 
hypothalamic GnRH which stimulates the release of LH into the circulation system 
(Shah et al., 2019). In the testis, the increase in the secretion of testosterone is caused 
by the binding of LH to the receptors situated on the Leydig cells (Karacaoğlu and 
Selmanoğlu, 2018; Khalid et al., 2018). Similarly, whenever the testosterone level 
within the blood circulation gets to its basic limit, it will bind to androgen receptors on 
the nerve center and anterior pituitary, thereby suppressing the synthesis and release 
of GnRH and LH, separately. In any event of a decrease in testosterone level, the 
hormone does not bind with the receptors to a similar manner as before, therefore 
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GnRH and LH are again released as well as stimulating more testosterone generation 
(Egba et al., 2017). 
2.3.6 Role of inducible nitric oxide synthase in male reproduction 
Recently, the role of inducible nitric oxide synthase (iNOS) an isoform of nitric 
oxide synthase (NOS) in the male reproductive system has been elucidated and the 
direct relationship of dietary factors such as cholesterol, fatty acids and vitamins with 
constitutive and inducible NO production in mammalian cells have also been 
established in previous studies (Lee and Yan, 2003; Sohrabi et al., 2017). 
One of the known mechanisms of immune defence that triggers cytokines 
against inflammation, infection and cancer is the induction of iNOS, this may occur 
without any underlying pathological condition especially in the brain, testis and penis 
leading to an increased level of NO in these tissues (Vernet et al., 1995; El-Sweedy et 
al., 2007). The increased NO, as a result, leads to the formation of peroxynitrite which 
causes apoptosis and subsequently proteolysis. In the penis of an obese person, this 
process could cause the loss of smooth muscle and nerve tissue involved in the erectile 
response (Cheng et al., 2004).  
It is worthy to note that the effects of neuronal nitric oxide synthase (nNOS) 
and endothelial nitric oxide synthase (eNOS) in the synthesis of nitric oxide as a 
mediator of penile erection, are well established. In penis, two main sources for the 
release of NO have been identified; these are the non-adrenergic noncholinergic nerve 
terminals and endothelium lining of the cavernosal cisternae as well as blood vessels, 
together they stimulate the guanylate cyclase and cGMP synthesis in the penile smooth 
muscle. The reduction of intracellular Ca2+ causes relaxation of the penile tissue, 
leading to increased blood flow into the corporal sinusoids and culminating into 
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swelling of the penis. In rat penis, for example, nNOS and eNOS enzymes catalyze 
NO synthesis by the conversion of L-arginine to L-citrulline (Garban et al., 1997). 
The male sexual act is divided into four phases: excitement, plateau, orgasm, 
and resolution which collectively is termed as "sexual response cycle" (Boily et al., 
2009). In man, several changes occur during this act, for instance, there are visible 
vascular responses such as skin flush, penile erection, and rise in blood pressure; 
glandular secretions (Cowper's glands, seminal vesicles, prostate); and stimulation of 
penile muscles, culminating into seminal emission and ejaculation (Estrada-Reyes et 
al., 2019). This is achieved by nitric oxide (NO) which is the main intermediary of 
penile erection. (Champion et al., 1999; Magee et al., 2002).  
2.3.7 Oxidative stress in the testis 
The imbalance between oxidation and reduction reactions in a particular 
system which leads to increase generation oxidants is referred to oxidative stress 
(Wagner et al., 2018). In other words, oxidative stress occurs when the generation of 
reactive oxygen species (ROS) supersedes the antioxidants generated by the body, 
culminating into cellular damage. One of the main derivatives of oxygen (O2) is ROS. 
It is worthy to note that some ROS are not true free radicals, for instance, H2O2.  
Peroxyl (ROO·) and hydroxyl (OH-) radicals, superoxide (O2
-) anion, and hydrogen 
peroxide (H2O2) are all ROS. Nitric oxide (NO
-) and peroxynitrite anion (ONOO-) 
though not regarded as ROS play an important role in reactions in infertility 
(Bhattacharya, 2015).  
Most infertile men have oxidative stress as the main causative factor of 
infertility and testicular oxidative stress have been linked to some environmental 
pollutants. During metabolism in the body, energy is released as a result of oxidative 
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phosphorylation which occurs in the mitochondria where free radicals are formed. This 
is defined as having one or more unpaired electrons in the outermost orbital of an 
oxygen atom. ROS induces cyclic adenosine monophosphate (cAMP) in spermatozoa 
that inhibit tyrosine phosphatase leading to tyrosine phosphorylation.  
 H2O2 stimulates capacitation via tyrosine phosphorylation triggering a cell 
signalling cascade. Capacitation not only requires ROS, but it can be inhibited by 
catalase (CAT) (Bardaweel et al., 2018). It has been described that high levels of ROS 
promote the acrosome reaction, whereas the presence of CAT or superoxide dismutase 
(SOD) inhibits the acrosome reaction. Measurement of MDA appears to be of some 
clinical relevance since its concentration within both seminal plasma and sperm is 
elevated in infertile men with excess ROS production, compared with fertile controls 
or normozoospermic individuals (Deshpande et al., 2018).  
As oxidative stress is the result of an imbalance between ROS production and 
total antioxidant capacity (TAC), direct tests reflect the net biological effect between 
these two opposing forces. The most widely used method of assessing sperm 
membrane peroxidation is the measurement of MDA levels in sperm or seminal 
plasma with the thiobarbituric acid assay (Meitern, 2016). 
2.3.8 Inflammation in the testis 
The testis has been reported to play an important role in the immune system 
while performing its traditional role of maintaining spermatogenesis, it also has the 
immune-testicular barrier which explains the increased in the proportion of 
CD8+/CD4+ within the testis in relation to the systemic circulation (Li et al., 2012). 
The following types of cells are found within the testis; they are macrophages, 
immune, natural killer and mast cells however, the presence of lymphocytes in the 
